The established risk factors for post‐SVR HCC after interferon (IFN) treatment are reportedly male gender, older age at the time of SVR, and severe fibrosis before treatment, as indicated by histological fibrosis grade F3 or F4, high aspartate aminotransferase (AST) level, low albumin level, and aspartate aminotransferase‐to‐platelet ratio index (APRI) ≥ 2.1, 2, 3, 4, 5 In addition, some articles reported high alpha‐fetoprotein (AFP) levels after treatment,3, 4 HCV genotype 3,5 and diabetes5 as risk factors for HCC. Here, AFP is linked to hepatocellular carcinoma.